Part 1 of our Ayurvedic Medicine in Contemporary Times series discussed the regulations and clinical evaluations governing Ayurvedic drugs and proprietary Ayurvedic medicines. The recent global resurgence of Ayurveda and a renewed interest in nutraceuticals and supplements derived from natural sources has led to an increased demand for biological resources. While this trend does lay emphasis on sustainable farming practices and effective resource management, not every natural product qualifies as an Ayurvedic product despite natural biological resources, such as plants, animal extracts, and minerals, being the primary building blocks of these Ayurvedic single-ingredient drugs or compound formulations.
Latest Post
More Posts
Ayurvedic Medicine in Contemporary Times: Part 1 – Understanding Clinical Evaluation and Drug Development
The National Medical Devices Policy, 2023: A Closer Look at Strategy and Implementation
Encapsulating the Branded vs. Generics Debate: Pitfalls and Doctors’ Dilemma
What Does the Box Say? Exploring the legality of advertisement strategies commonly deployed by FMCG Companies
The Operation of e-Pharmacies and Data Privacy Risks
Examining the Regulatory and Operational Issues Affecting M&A in Pharmaceuticals and Healthcare Industry
Pharmaceutical and Healthcare Industry: A Case for Regulation Through Blockchain
Consent in Healthcare: Outline, Gaps and Conundrum (Part 2)
Consent in Healthcare: Outline, Gaps and Conundrum (Part 1)
Subscribe: Subscribe via RSS
Blogs
Firm/Org